Relevance of cellular to clinical electrophysiology in interpreting antiarrhythmic drug action

Related Experiment Video

Updated: Jul 20, 2026

Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
08:03

Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation

Published on: October 20, 2022

E M Vaughan Williams1

  • 1Herford College, University of Oxford, United Kingdom.

The American Journal of Cardiology
|December 5, 1989
PubMed

Insights

Cellular electrophysiology explains antiarrhythmic drug actions and clinical effects. Understanding drug interactions with sodium channels and sympathetic activity is key to treating arrhythmias effectively.

Area of Science:

  • Cardiovascular Pharmacology
  • Clinical Electrophysiology
  • Cardiac Electrophysiology

Background:

  • Cellular electrophysiologic techniques are crucial for understanding antiarrhythmic drug mechanisms.
  • Clinical electrophysiologists' findings can be explained by cellular drug actions.

Purpose of the Study:

  • To contrast the utility of cellular electrophysiology in explaining drug actions versus guiding clinical drug selection.
  • To elucidate the cellular electrophysiologic basis for the clinical efficacy of various antiarrhythmic drug classes.

Main Methods:

  • Analysis of cellular electrophysiologic properties of antiarrhythmic drugs.
  • Correlation of cellular drug actions with clinical effects in different arrhythmia types.
  • Examination of the role of sympathetic activity and adrenoceptor stimulation in arrhythmogenesis.

Main Results:

  • Clinical effects of Class IA, IB, and IC agents correlate with their sodium channel binding kinetics.
  • Sympathetic activity's role in arrhythmias is explained by adrenoceptor electrophysiology.
  • Delayed repolarization is antiarrhythmic when homogeneous; heterogeneous prolongation (e.g., Long QT syndrome) increases arrhythmia risk.
  • Class IV calcium antagonists' efficacy in supraventricular arrhythmias is linked to nodal cell electrophysiology.

Conclusions:

  • Cellular electrophysiology provides a fundamental framework for understanding antiarrhythmic drug efficacy and clinical application.
  • Drug selection for specific arrhythmias can be informed by understanding cellular electrophysiologic properties and their impact on cardiac ion channels and sympathetic modulation.

More Related Videos

Laser-Induced Action Potential-Like Measurements of Cardiomyocytes on Microelectrode Arrays for Increased Predictivity of Safety Pharmacology10:41

Laser-Induced Action Potential-Like Measurements of Cardiomyocytes on Microelectrode Arrays for Increased Predictivity of Safety Pharmacology

Published on: September 13, 2022

Measurement of Heart Contractility in Isolated Adult Human Primary Cardiomyocytes09:17

Measurement of Heart Contractility in Isolated Adult Human Primary Cardiomyocytes

Published on: August 9, 2022

Related Concept Videos

Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase of...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Cardiac Action Potential01:30

Cardiac Action Potential

Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials